Institute of Liver and Biliary Sciences, India: Hepatitis trials

The registry lists 17 Hepatitis studies with Institute of Liver and Biliary Sciences, India as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 2 1Phase 3 1No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of Therapeutic Plasma Exchange vs Standard Medical Therapy in Severe Autoimmune Hepatitis.Not yet recruitingNCT06855667Not applicable
• Randomized Controlled Trial of Mycophenolate Mofetil Versus Steroid Therapy in Alcoholic HepatitisNot yet recruitingNCT06789315Not applicable
• Induction of Remission in Autoimmune Hepatitis With Azathioprine vs. MMFNot yet recruitingNCT06650124Phase 2/3
• Efficacy of Plasma Exchange Therapy vs Standard Medical Therapy in Severe Alcoholic Hepatitis With High Discriminant FunctionRecruitingNCT06355726Not applicable
• Role of Extended Low Dose Prednisolone in Achieving Clinical and Biochemical Remission in Steroid Responsive Severe Alcoholic HepatitisNot yet recruitingNCT06155760Not applicable
• Fecal Microbiota Therapy in Steroid Ineligible Alcoholic HepatitisStatus unknownNCT05285592Not applicable
• Effect of Saturated Fat (Desi Ghee) on Gut-Liver Axis in Alcoholic HepatitisCompletedNCT04084522Not applicable
• Efficacy of Monotherapy vs Combination Therapy of Corticosteroids With GCSF in Severe Alcoholic Hepatitis Patients.Status unknownNCT04066179Not applicable
• To Study the Efficacy of PEG-IFN Alpha in HBeAg Negative Chronic Hepatitis B Patients After Stopping Nucleotide Analogue Therapy.Status unknownNCT03123653Not applicable
• A Comparison of Fecal Microbiota Transplantation and Steroid Therapy in Patients With Severe Alcoholic Hepatitis.Status unknownNCT03091010Not applicable
• Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver DiseaseWithdrawnNCT02658786
• Safety and Efficacy of Sofosbuvir Based Antiviral Regimen for Treating Hepatitis C in Patients With Moderate to Advanced Chronic Kidney Disease and Patients Receiving Renal Replacement TherapyWithdrawnNCT02563665
• Pentoxyphilline Versus Fecal Microbiota Therapy in Severe Alcoholic HepatitisCompletedNCT02458079Not applicable
• To Compare The Efficacy Of N -Acetylcysteine and Standard Therapy Versus Standard Therapy In The Prevention Of Ischemic Hepatitis And Survival Post Upper GI BleedCompletedNCT02015403Not applicable
• Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic HepatitisCompletedNCT01820208Not applicable
• To Compare the Efficacy of Combined Tenofovir Plus Telbivudine vs Tenofovir Alone in Patients With Spontaneous Reactivation of Hepatitis BCompletedNCT01732224Not applicable
• Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B PatientsWithdrawnNCT01260610Not applicable